Search Results for "Takeda"

20:10 EDT 28th July 2016 | BioPortfolio

Matching Channels

Pertussis Vaccine acellular Takeda

The Top 100 Drugs

The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...

Matching News

Figure: Tracking Takeda

Taking Takeda global Tracking Takeda Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) wants to maintain its position in the top 10 cancer companies and become the number one GI company in the next five to ...

Teva and Takeda establish ‘Teva Takeda Yakuhin’ in Japan

Israeli generics giant Teva Pharmaceutical Industries (Teva) and Japan-based Takeda Pharmaceutical Company (Takeda) have formed a joint company ‘Teva Takeda Yakuhin’ to produce and sell off-patent...

Takeda's Brintellix Renamed Trintellix

​Takeda Pharmaceuticals U.S.A., Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502) (collectively “Takeda”), and Lundbeck announced that Brintellix(vortioxetine) ...

Orexigen and Takeda Jointly Announce Orexigen's Acquisition of All Rights to CONTRAVE® in United States

San Diego, CA and Deerfield, Ill., and Osaka, Japan, March 15, 2016 – Orexigen Therapeutics, Inc. (Nasdaq: OREX) and Takeda Pharmaceuticals U.S.A., Inc., a wholly-owned subsidiary of Takeda Phar...

Takeda Licenses Global Rights to Theravance Biopharma's TD-8954, a Novel 5-HT4 Agonist and Motility Agent for Gastrointestinal Motility Disorders / Deal Provides Takeda Global Rights to Selective 5-HT4 Agonist; Highlights Takeda's Commitment to Gastroent

DUBLIN, IRELAND and OSAKA, JAPAN -- (Marketwired) -- 06/08/16 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Takeda Pharmaceutical Company Limited (TSE: 4502) ("Takeda")...

Takeda and Teva Establish "Teva Takeda Yakuhin Ltd." in Japan

Takeda Research Investment: How Investments are Chosen

In this episode of PharmaTelevision News Review, Fintan Walton talks with Graeme Martin, President & CEO at Takeda Research Investment. Filmed at BioTrinity 2010 in Newbury, UK, they discuss: • TRI...

Takeda make a strategic acquisition

In this episode of PharmaTelevision News Review, Fintan Walton talks to Nigel Borshell, Director at PharmaVentures. Nycomed’s geographic presence in Europe and Emerging markets a strong justificati...

Matching PubMed Articles

Quantitative determination of the antidepressant vortioxetine and its major human metabolite in plasma.

Vortioxetine is a novel antidepressant that has been developed in a joint partnership between H. Lundbeck A/S and the Takeda Pharmaceutical Company, Ltd.

Metabolic effects of bile acid sequestration: impact on cardiovascular risk factors.

This article discusses the impact of bile acid sequestrants (BAS) on cardiovascular risk factors (CVRFs), on the basis of recent (pre)clinical studies assessing the metabolic impact of modulation of e...

Efficacy of Human Fibrinogen-Thrombin Patch (TachoSil) Clinical Application in Upper Gastrointestinal Cancer Surgery.

Previous studies investigated the efficacy and applicability of tissue adhesives in gastrointestinal surgery while no evidence is available to date about a novel compound, TachoSil (Takeda, Zurich, Sw...

Efficacy and safety of human fibrinogen-thrombin patch (Tachosil(®)) in the management of diffuse bleeding after chest wall and spinal surgical resection for aggressive thoracic neoplasms.

Diffuse bleeding after chest wall and spine resection represents a major problem in General Thoracic Surgery. Several fibrin sealants (FS) have been developed over the years and their use has been gra...

Vaccines against norovirus: state of the art trials in children and adults.

Noroviruses (NoVs), a group of nonenveloped, single-stranded RNA viruses belonging to the Caliciviridae family, are the leading cause worldwide of acute infectious gastroenteritis. Serious and eventua...

Search Whole site using Google

Quick Search
Advertisement Advertisement